Thiết kế và Tối ưu hóa vắc-xin BCG dạng bột khô ổn định nhiệt độ

Persson S. Smallpox, syphilis and salvation: medical breakthroughs that changed the world [internet]. Exisle Publishing; 2010. Available: https://books.google.com/books?id=ZA0v9N7S2LgC&pgis=1 Nabel GJ. Designing Tomorrow’s vaccines. N Engl J Med. 2013;368:551–60. https://doi.org/10.1056/NEJMra1204186. Wang G, Cao R-Y, Chen R, Mo L, Han J-F, Wang X, et al. Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc Natl Acad Sci U S A. 2013;110:7619–24. https://doi.org/10.1073/pnas.1300233110. Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond Ser B Biol Sci. 2014;369:20130433. https://doi.org/10.1098/rstb.2013.0433. Matthias D, Robertson J, Garrison M, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007;25:3980–6. https://doi.org/10.1016/j.vaccine.2007.02.052. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet Elsevier. 2010;375:1969–87. https://doi.org/10.1016/S0140-6736(10)60549-1. Organization WH. Global Health Observatory data - immunization [internet]. World Health Organization; 2014. Available: http://www.who.int/gho/immunization/en/ Galazka A, Milstien J, Zaffran M. Thermostability of vaccines. World Heal Organ Geneva. 1998; Available: http://apps.who.int/iris/bitstream/10665/64980/1/WHO_GPV_98.07.pdf Cheyne J. Vaccine delivery management. Clin Infect Dis. 1989;11:S617–22. https://doi.org/10.1093/clinids/11.Supplement_3.S617. Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. In: Health Affairs [Internet]. 2011; pp. 1113–1121. https://doi.org/10.1377/hlthaff.2011.0368 Lerman SJ. Measles in children previously vaccinated against measles. JAMA. 1971;216:1311. https://doi.org/10.1001/jama.1971.03180340031007. Krugman RD, Meyer BC, Enterline JC, Parkman PD, Witte JJ, Meyer HM. Impotency of live-virus vaccines as a result of improper handling in clinical practice. J Pediatr. 1974;85:512–4. https://doi.org/10.1016/S0022-3476(74)80455-5. World Health Organization (WHO). Temperature sensitivity of vaccines. 2006; 63. doi:WHO/IVB/06.10. World Health Organization. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. World Health Organization; Available: http://www.who.int/bulletin/volumes/91/12/13-119974/en/ Zhang J, Pritchard E, Hu X, Valentin T, Panilaitis B, Omenetto FG, et al. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A. 2012;109:11981–6. https://doi.org/10.1073/pnas.1206210109. Garcia-Contreras L, Wong Y-L, Muttil P, Padilla D, Sadoff J, Derousse J, et al. Immunization by a bacterial aerosol. Proc Natl Acad Sci U S A. 2008;105:4656–60. https://doi.org/10.1073/pnas.0800043105. Mansour HM, Xu Z, Hickey AJ. Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends : 3 . Trehalose Dihydrate and D -Mannitol Carriers. J Pharm Sci. 2010;99:3430–41. https://doi.org/10.1002/jps. Amorij J-P, Huckriede A, Wilschut J, Frijlink HW, Hinrichs WLJ. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res. 2008;25:1256–73. https://doi.org/10.1007/s11095-008-9559-6. Jin TH, Tsao E, Goudsmit J, Dheenadhayalan V, Sadoff J. Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402). Vaccine Elsevier Ltd. 2010;28:4369–75. https://doi.org/10.1016/j.vaccine.2010.04.059. Corbanie EA, Remon JP, Van Reeth K, Landman WJM, van Eck JHH, Vervaet C. Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry. Vaccine. 2007;25:8306–17. https://doi.org/10.1016/j.vaccine.2007.09.049. Sou T, Kaminskas LM, Nguyen T-H, Carlberg R, McIntosh MP, Morton DAV. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Eur J Pharm Biopharm. 2012;83:234–43. https://doi.org/10.1016/j.ejpb.2012.10.015. Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25:999–1022. https://doi.org/10.1007/s11095-007-9475-1. Kunda NK, Wafula D, Tram M, Wu TH, Muttil P. A stable live bacterial vaccine. Eur J Pharm Biopharm. 2016;103:109–17. https://doi.org/10.1016/j.ejpb.2016.03.027. Saboo S, Tumban E, Peabody J, Wafula D, Peabody DS, Chackerian B, et al. Optimized formulation of a Thermostable spray-dried virus-like particle vaccine against human papillomavirus. Mol Pharm. 2016;13:1646–55. https://doi.org/10.1021/acs.molpharmaceut.6b00072. McAdams D, Chen D, Kristensen D. Spray drying and vaccine stabilization. Expert Rev Vaccines. 2012;11:1211–9. https://doi.org/10.1586/erv.12.101. Sou T, Meeusen EN, de Veer M, Morton DAV, Kaminskas LM, McIntosh MP. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol. 2011;29:191–8. https://doi.org/10.1016/j.tibtech.2010.12.009. Geller DE, Weers J, Heuerding S. Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology. J Aerosol Med Pulm Drug Deliv. 2011;24:175–82. https://doi.org/10.1089/jamp.2010.0855. Dharmadhikari AS, Kabadi M, Gerety B, Hickey AJ, Fourie PB, Nardell E. Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis. Antimicrob Agents Chemother. 2013;57:2613–9. https://doi.org/10.1128/AAC.02346-12. Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci. 2007;32:140–50. https://doi.org/10.1016/j.ejps.2007.06.006. Zwerling A, Pai M. The BCG world atlas: a new, open-access resource for clinicians and researchers. Expert Rev Anti-Infect Ther. 2011;9:559–61. https://doi.org/10.1586/eri.11.71. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3:656–62. https://doi.org/10.1038/nrmicro1211. McShane H. Understanding BCG is the key to improving it. Clin Infect Dis. 2013;58:481–2. https://doi.org/10.1093/cid/cit793. Shur J, Nevell TG, Ewen RJ, Price R, Smith A, Barbu E, et al. Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy. J Pharm Sci. 2008;97:4857–68. https://doi.org/10.1002/jps.21362. Ohrem HL, Schornick E, Kalivoda A, Ognibene R. Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms? Pharm Dev Technol. 2014;19:257–62. https://doi.org/10.3109/10837450.2013.775154. Gonnissen Y, Remon JP, Vervaet C. Development of directly compressible powders via co-spray drying. Eur J Pharm Biopharm. 2007;67:220–6. https://doi.org/10.1016/j.ejpb.2006.12.021. Gonnissen Y, Remon JP, Vervaet C. Effect of maltodextrin and superdisintegrant in directly compressible powder mixtures prepared via co-spray drying. Eur J Pharm Biopharm. 2008;68:277–82. https://doi.org/10.1016/j.ejpb.2007.05.004. Liao Y-H, Brown MB, Nazir T, Quader A, Martin GP. Effects of sucrose and trehalose on the preservation of the native structure of spray-dried lysozyme. Pharm Res. 2002;19:1847–53 Available: http://www.ncbi.nlm.nih.gov/pubmed/12523664. Nguyen XC, Herberger JD, Burke PA. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm Res. 2004;21:507–14. https://doi.org/10.1023/B:PHAM.0000019306.89420.f0. Garmise RJ, Staats HF, Hickey AJ. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech. 2007;8:E81. https://doi.org/10.1208/pt0804081. Maury M, Murphy K, Kumar S, Mauerer A, Lee G. Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G. Eur J Pharm Biopharm. 2005;59:251–61. https://doi.org/10.1016/j.ejpb.2004.07.010. Adler M, Lee G. Stability and surface activity of lactate dehydrogenase in spray-dried trehalose. J Pharm Sci. 1999;88:199–208. https://doi.org/10.1021/js980321x. Andya JD, Maa YF, Costantino HR, Nguyen PA, Dasovich N, Sweeney TD, et al. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm Res. 1999;16:350–8 Available: http://www.ncbi.nlm.nih.gov/pubmed/10213364. Peyre M, Audran R, Estevez F, Corradin G, Gander B, Sesardic D, et al. Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J Control Release. 2004;99:345–55. https://doi.org/10.1016/j.jconrel.2004.07.014. Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res. 1998;15:1103–10 Available: http://www.ncbi.nlm.nih.gov/pubmed/9688067. Dani B, Platz R, Tzannis ST. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration. J Pharm Sci. 2007;96:1504–17. https://doi.org/10.1002/jps.20508. Liao Y-H, Brown MB, Jones SA, Nazir T, Martin GP. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers. Int J Pharm. 2005;304:29–39. https://doi.org/10.1016/j.ijpharm.2005.07.013. Zeng XM, Martin GP, Marriott C. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose. Int J Pharm. 2001;218:63–73. https://doi.org/10.1016/S0378-5173(01)00613-5. Mahlin D, Berggren J, Gelius U, Engström S, Alderborn G. The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles. Int J Pharm. 2006;321:78–85. https://doi.org/10.1016/j.ijpharm.2006.05.016. Hawe A, Friess W. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations. Eur J Pharm Sci. 2006;28:224–32. https://doi.org/10.1016/j.ejps.2006.02.003. Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Préat V, et al. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Control Release. 2004;99:357–67. https://doi.org/10.1016/j.jconrel.2004.07.022. Wong Y-L, Sampson S, Germishuizen WA, Goonesekera S, Caponetti G, Sadoff J, et al. Drying a tuberculosis vaccine without freezing. Proc Natl Acad Sci U S A. 2007;104:2591–5. https://doi.org/10.1073/pnas.0611430104. National Research Council (US) Committee. Guide for the Care and Use of Laboratory Animals [Internet]. National Academies Press (US); 2011. Available: http://www.ncbi.nlm.nih.gov/books/NBK54050/ Price DN, Kusewitt DF, Lino CA, McBride AA, Muttil P. Oral tolerance to environmental mycobacteria interferes with intradermal, but not pulmonary, immunization against tuberculosis. PLOS Pathog Public Libr Sci. 2016;12:e1005614. https://doi.org/10.1371/journal.ppat.100561. ICH. Stability testing of new drug substances and products Q1A(R2). Int Conf Harmon. 2003; 24. https://doi.org/10.1136/bmj.333.7574.873-a ICH. Q5C Stability Testing of Biotechnological/Biological Products. ICH Harmon Tripart Guidel. 1995; 1–8. World Health Organization. Vaccine Handling [Internet]. Available: http://extranet.who.int/ivb_policies/reports/vaccine_handling.pdf Schaltz-Buchholzer F, Frankel HN, Benn CS. The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial. Glob Health Action Taylor Francis. 2017;10:1–4. https://doi.org/10.1080/16549716.2017.1267964. Saluja V, Amorij J-P, Kapteyn JC, de Boer AH, Frijlink HW, Hinrichs WLJ. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Control Release. Elsevier B.V. 2010;144:127–33. https://doi.org/10.1016/j.jconrel.2010.02.025. Lu D, Garcia-Contreras L, Muttil P, Padilla D, Xu D, Liu J, et al. Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J Springer N Y. 2010;12:338–47. https://doi.org/10.1208/s12248-010-9193-1. Mensink MA, Frijlink HW, van der Voort MK, Hinrichs WLJ. How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions. Eur J Pharm Biopharm Elsevier. 2017;114:288–95. https://doi.org/10.1016/J.EJPB.2017.01.024. Duddu SP, Dal Monte PR. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody. Pharm Res. 1997;14:591–5 Available: http://www.ncbi.nlm.nih.gov/pubmed/9165528. Izutsu K, Yoshioka S, Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. Chem Pharm Bull (Tokyo). 1994;42:5–8 Available: http://www.ncbi.nlm.nih.gov/pubmed/8124765. Costantino HR, Andya JD, Nguyen PA, Dasovich N, Sweeney TD, Shire SJ, et al. Effect of Mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J Pharm Sci. 1998;87:1406–11. https://doi.org/10.1023/A:1018805232453. Leung SSY, Parumasivam T, Gao FG, Carter EA, Carrigy NB, Vehring R, et al. Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders. Int J Pharm NIH Public Access. 2017;521:141–9. https://doi.org/10.1016/j.ijpharm.2017.01.060. Zipursky S, Djingarey MH, Lodjo J-C, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccines out of the cold chain: delivering meningitis a vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine. 2014;32:1431–5. https://doi.org/10.1016/j.vaccine.2014.01.038. Kahn A-L, Kristensen D, Rao R. Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines. Vaccine. 2017;35:2214–6. https://doi.org/10.1016/j.vaccine.2016.10.091. Chang BS, Mahoney RR. Enzyme thermostabilization by bovine serum albumin and other proteins: evidence for hydrophobic interactions. Biotechnol Appl Biochem. 1995;22:203–14 Available: http://www.ncbi.nlm.nih.gov/pubmed/7576258. Price DN, Muttil P. Directed Intervention and Immunomodulation against Pulmonary Tuberculosis. In: Torchilin V, editor. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Chichester: John Wiley & Sons, Ltd; 2016. p. 346–77. https://doi.org/10.1002/9781118943182.ch18. Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2012;12:581–91. https://doi.org/10.1038/nri3259.